3 completed, 1 unknown. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
Follow Reflux: new trials by email Literature Review of Reflux trials Research Report on Reflux
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? Quercetin - Gastroesophageal Reflux Disease, GERD | Phase 1 | Completed | University of North Carolina, Chapel Hill | 26 | 2014-08-01 | 2016-12-20 |
| Renal Impairment Study AZD3355 - Reflux, Renal Excretion | Phase 1 | Completed | AstraZeneca | 23 | 2009-03-01 | 2011-01-24 |
| Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD) esomeprazole magnesium - Endoscopically-Proven GERD, Reflux | Phase 1 | Completed | AstraZeneca | 40 | 2006-08-01 | 2008-06-11 |
| The Effect of Nexium on Transmucosal Esophageal Leak Esomeprazole (Nexium) 40 mg/day - Reflux, Esophagitis | Phase 1 | Unknown | Main Line Health | 35 | 2006-01-01 | 2010-03-16 |
Gastroesophageal Reflux (4) · Barrett Esophagus (1) · Esophagitis (1)
Deglutition Disorders (4) · Digestive System Diseases (4) · Esophageal Diseases (4) · Esophageal Motility Disorders (4) · Gastrointestinal Diseases (4) · Gastroenteritis (1) · Neoplasms (1) · Precancerous Conditions (1)
Esomeprazole (2) · Quercetin (1) · lesogaberan (1)
AstraZeneca (2) · Main Line Health (1) · University of North Carolina, Chapel Hill (1)
United States (2) · Sweden (1)
James M Mullin, Ph.D. (1) · Lynne Durborow (1) · Marta Illueca (1) · Nicholas Shaheen, MD, MPH (1) · Wolfgang Kuhn, MD (1)
R21DK097529 (1)